Yande Huang Selected Research

2- (2- (1- (2- chlorophenyl)- 1- methylethyl)- 1- (3'- (methylsulfonyl)- 4- biphenylyl)- 1H- imidazol- 4- yl)- 2- propanol

4/2016

Dehydration and Stabilization of a Reactive Tertiary Hydroxyl Group in Solid Oral Dosage Forms of BMS-779788.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yande Huang Research Topics

Disease

2	Hepatitis C 10/2019 - 08/2019
2	Virus Diseases (Viral Diseases) 10/2019 - 08/2019
2	Dehydration (Water Stress) 01/2018 - 04/2016
1	Type 2 Diabetes Mellitus (MODY) 02/2006

Drug/Important Bio-Agent (IBA)

1	Pharmaceutical PreparationsIBA 10/2019
1	daclatasvirIBA 10/2019
1	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 08/2019
1	OxidesIBA 01/2018
1	Dosage Forms (Dosage Form)IBA 04/2016
1	SolutionsIBA 04/2016
1	Hydroxyl RadicalIBA 04/2016
1	2- (2- (1- (2- chlorophenyl)- 1- methylethyl)- 1- (3'- (methylsulfonyl)- 4- biphenylyl)- 1H- imidazol- 4- yl)- 2- propanolIBA 04/2016
1	AcidsIBA 04/2016
1	Methanol (Carbinol)IBA 04/2016
1	Alkenes (Olefins)IBA 04/2016
1	imidazoleIBA 04/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2006
1	muraglitazarIBA 02/2006